Atherogenic indices in non-arteritic ischemic optic neuropathy.
atherogenic index
atherosclerosis
lipid profile
non-arteritic ischemic optic neuropathy
second eye involvement
Journal
International journal of ophthalmology
ISSN: 2222-3959
Titre abrégé: Int J Ophthalmol
Pays: China
ID NLM: 101553860
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
11
2020
accepted:
22
01
2021
entrez:
20
7
2021
pubmed:
21
7
2021
medline:
21
7
2021
Statut:
epublish
Résumé
To evaluate the atherogenic indices and the relationship with visual acuity and bilateral sequential involvement in patients with non-arteritic ischemic optic neuropathy (NAION). A total of 65 patients with NAION and 48 age-sex matched healthy individuals were included in this retrospective study. The demographic characteristics and laboratory findings of the patients and control subjects were obtained from the electronic medical records. The atherogenic indices were calculated using the lipid parameters. The association between visual acuity, bilateral sequential involvement, and atherogenic indices was investigated. The mean age was 63.8±12.5y in the NAION group and 64.7±10.1y in control group ( The study reveals a relationship between NAION and the non-traditional lipid ratios. Atherogenic indices may predict the visual loss severity and second eye involvement in patients with NAION.
Identifiants
pubmed: 34282389
doi: 10.18240/ijo.2021.07.12
pii: ijo-14-07-1041
pmc: PMC8243175
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1041-1046Informations de copyright
International Journal of Ophthalmology Press.
Références
Am J Ophthalmol. 2016 Oct;170:183-189
pubmed: 27521605
Am J Ophthalmol. 1994 Dec 15;118(6):766-80
pubmed: 7977604
BMC Ophthalmol. 2017 Aug 24;17(1):155
pubmed: 28836961
Circulation. 2006 Feb 7;113(5):657-63
pubmed: 16461838
Z Rheumatol. 2017 Apr;76(3):259-266
pubmed: 27431747
J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):947-955
pubmed: 28787273
Heart Lung Circ. 2020 Mar;29(3):414-421
pubmed: 31014557
Arch Ophthalmol. 1997 Nov;115(11):1403-7
pubmed: 9366670
PLoS One. 2019 Nov 14;14(11):e0225322
pubmed: 31725805
N Engl J Med. 2007 Sep 27;357(13):1301-10
pubmed: 17898099
PLoS One. 2018 Jun 28;13(6):e0199793
pubmed: 29953490
Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2255-2261
pubmed: 28861697
J Cardiol. 2018 Jan;71(1):8-9
pubmed: 29033056
Neuroepidemiology. 2013;40(3):220-4
pubmed: 23364133
JAMA. 2009 Nov 11;302(18):1993-2000
pubmed: 19903920
J Neuroophthalmol. 2005 Mar;25(1):22-4
pubmed: 15756128
Am J Ophthalmol. 2002 Sep;134(3):317-28
pubmed: 12208242
J Diabetes Complications. 2019 Feb;33(2):118-122
pubmed: 30522790
PLoS One. 2016 Apr 26;11(4):e0154345
pubmed: 27115999
Int J Cardiol. 2013 Oct 3;168(3):2678-83
pubmed: 23545148
Curr Opin Ophthalmol. 2002 Dec;13(6):357-61
pubmed: 12441837
Eye (Lond). 2000 Feb;14 ( Pt 1):118
pubmed: 10755123
Eye (Lond). 2019 Jul;33(7):1140-1144
pubmed: 30833666
Curr Vasc Pharmacol. 2018;16(6):589-595
pubmed: 29299987
Physiol Res. 2017 May 4;66(2):193-203
pubmed: 28471688
Circulation. 2005 Nov 29;112(22):3368-70
pubmed: 16316961
Br J Ophthalmol. 2008 Dec;92(12):1577-80
pubmed: 19029161
J Am Coll Cardiol. 2009 Dec 29;55(1):35-41
pubmed: 20117361
J Intern Med. 2010 Dec;268(6):567-77
pubmed: 21091808
Eye (Lond). 1995;9 ( Pt 1):85-8
pubmed: 7713255
Am J Ophthalmol. 1997 Feb;123(2):212-7
pubmed: 9186127
Ophthalmology. 2003 May;110(5):1041-6; discussion 1046
pubmed: 12750110